2nd Annual Life Science Regulatory Intelligence, Strategy and Execution Conference

November 12-13, 2019 | Alexandria, VA

Sheraton Suites Old Town Alexandria

Download AgendaRegister Now

DISTINGUISHED PRESENTERS INCLUDE:

Jessica Hale, Pharma.D
Senior Specialist, Regulatory Affairs, Devices & Digital Health
MERCK

Charles Celeste
Director, Regulatory Policy & Intelligence
LEO PHARMA

Meg Drew
Director, Global Regulatory Strategy
ABBVIE

Lisa Wells
Regulatory Affairs/Medical Products
W.L. GORE & ASSOCIATES

Jessica Schlegel
Sr. Specialist Device and Digital Health
MERCK

William Garvin
Shareholder
BUCHANAN, INGERSOLL & ROONEY

Linda Bowen
Head of Regulatory Policy and Intelligence
SEATTLE GENETICS

Richard Jahn
Senior Director, Regulatory Policy & Intelligence
PFIZER

Janet Vessotskie
Senior Director, Regulatory Intelligence & Policy
TAKEDA

Libette Luce
Senior Director, Global Regulatory Affairs
BAUSCH HEALTH

Julia Jiang
Independent Consultant
Former Global Regulatory Intelligence Lead, Otsuka Pharmaceutical

Chris Whalley
Senior Manager, Regulatory Policy and Intelligence
SEATTLE GENETICS

Vada Perkins
Head, Regulatory Intelligence, Director, Regulatory Policy & Intelligence
BAYER

Kirsten Paulson
Sr. Director, Global CMC – Medical Devices
PFIZER

Kimberly Belsky
Executive Director, Regulatory Policy & Intelligence
MALLINCKRODT PHARMACEUTICALS

Kendra Martello
Executive Director, Public Policy & Corporate Social Responsibility, Government Affairs & Public Policy
MALLINCKRODT PHARMACEUTICALS

Rachel Turow
Executive Counsel – Regulatory Law
TEVA PHARMACEUTICAL INDUSTRIES LTD.

Luke Zack
Senior Manager, Global Regulatory Affairs
KYOWA KIRIN PHARMACEUTICAL DEVELOPMENT